A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C

NCT02564497 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

491

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Transplantation

Interventions

BIOLOGICAL: Process E Belatacept
BIOLOGICAL: Process C Belatacept

Sponsor

Bristol-Myers Squibb